Ligand · L6G
L6G · (5R,8S,11S)-5-methyl-8-(propan-2-yl)-11-[(1E)-4-sulfanylbut-1-en-1-yl]-3,17-dithia-7,10,14,19,20-pentaazatricyclo[14.2.1.1~2,5~]icosa-1(18),2(20),16(19)-triene-6,9,13-trione
L6G, (5R,8S,11S)-5-methyl-8-(propan-2-yl)-11-[(1E)-4-sulfanylbut-1-en-1-yl]-3,17-dithia-7,10,14,19,20-pentaazatricyclo[14.2.1.1~2,5~]icosa-1(18),2(20),16(19)-triene-6,9,13-trione (C21 H29 N5 O3 S3, 495.7 g/mol), in the MolNFT structures on…
- Component
- L6G
- Formula
- C21 H29 N5 O3 S3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L6G in 2 structures; the first of them:
- 4RN0 · Crystal structure of S39D HDAC8 in complex with a largazole analogue. · L6G A501 · binds TYR100, HIS142, HIS143, GLY151, PHE152, ASP178, HIS180, PHE208 and 9 more
- 4RN0 · Crystal structure of S39D HDAC8 in complex with a largazole analogue. · L6G A501 · binds TYR100, HIS142, HIS143, GLY151, PHE152, ASP178, HIS180, PHE208 and 9 more
Residues it binds most
HIS 4, PHE 4, TYR 4, ASP 4, GLY 4, MET 4, LYS 4, PRO 4, ILE 2, LEU 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.